Cellular Pathology Referrals - University Hospitals Birmingham

{
  "awards": [
    {
      "id": "043424-2025-1",
      "relatedLots": [
        "1"
      ],
      "status": "active",
      "suppliers": [
        {
          "id": "GB-FTS-155770",
          "name": "University Hospitals Birmingham NHS Foundation Trust"
        }
      ]
    }
  ],
  "bids": {
    "statistics": [
      {
        "id": "1",
        "measure": "bids",
        "relatedLot": "1",
        "value": 1
      }
    ]
  },
  "buyer": {
    "id": "GB-FTS-148412",
    "name": "Gateshead Health NHS Foundation Trust"
  },
  "contracts": [
    {
      "awardID": "043424-2025-1",
      "dateSigned": "2025-07-25T00:00:00+01:00",
      "id": "043424-2025-1",
      "status": "active",
      "value": {
        "amount": 35000,
        "currency": "GBP"
      }
    }
  ],
  "date": "2025-07-28T12:29:36+01:00",
  "description": "This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2023 do not\napply to this award.\nThe standstill period begins on the day after the publication of this notice.\nRepresentations by providers must be made to the relevant authority by 6th August 2025.\nAddress for Written Representations: ghnt.psr@nhs.net\nThis contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.\nDetails of the Award Decision-Makers: Dr Kate MacDougal, Mrs S Whitlie.\nConflicts of Interest: There were no conflicts of interest identified among the decision makers.\nThis decision to proceed with Direct Award C is based on the following criteria: Second opinions are requested from experts in a chosen speciality that are employed in a UKAS accredited laboratory and participate in EQA for that speciality. Turnaround times for results are also a consideration for utilising the referral service with this provider. Test referrals are made to UKAS accredited laboratories with acceptable clinical interpretation,\navailability of clinical advice and turnarounds that facilitate compliance with RCPath guidelines. Referrals are often made in accordance with established regional referral pathways in line with MDT arrangements for tertiary specialities. Genomic test referrals are made in accordance with genomic hub guidelines.",
  "id": "043424-2025",
  "initiationType": "tender",
  "language": "en",
  "ocid": "ocds-h6vhtk-0566fe",
  "parties": [
    {
      "address": {
        "countryName": "United Kingdom",
        "locality": "Gateshead",
        "postalCode": "NE96SX",
        "region": "UKC22",
        "streetAddress": "Queen Elizabeth Hospital, Sheriff Hill"
      },
      "contactPoint": {
        "email": "ghnt.psr@nhs.net",
        "telephone": "+44 1914452801"
      },
      "details": {
        "classifications": [
          {
            "description": "Regional or local authority",
            "id": "REGIONAL_AUTHORITY",
            "scheme": "TED_CA_TYPE"
          },
          {
            "description": "Health",
            "id": "07",
            "scheme": "COFOG"
          }
        ],
        "url": "http://www.gatesheadhealth.nhs.uk"
      },
      "id": "GB-FTS-148412",
      "identifier": {
        "legalName": "Gateshead Health NHS Foundation Trust",
        "noIdentifierRationale": "notOnAnyRegister"
      },
      "name": "Gateshead Health NHS Foundation Trust",
      "roles": [
        "buyer"
      ]
    },
    {
      "address": {
        "countryName": "United Kingdom",
        "locality": "Birmingham",
        "postalCode": "B16 6TT",
        "region": "UK"
      },
      "details": {
        "scale": "large"
      },
      "id": "GB-FTS-155770",
      "identifier": {
        "legalName": "University Hospitals Birmingham NHS Foundation Trust",
        "noIdentifierRationale": "notOnAnyRegister"
      },
      "name": "University Hospitals Birmingham NHS Foundation Trust",
      "roles": [
        "supplier"
      ]
    },
    {
      "address": {
        "countryName": "United Kingdom",
        "locality": "London"
      },
      "id": "GB-FTS-132424",
      "identifier": {
        "legalName": "PSR Review Panel"
      },
      "name": "PSR Review Panel",
      "roles": [
        "reviewBody"
      ]
    }
  ],
  "tag": [
    "award",
    "contract"
  ],
  "tender": {
    "classification": {
      "description": "Services provided by medical laboratories",
      "id": "85145000",
      "scheme": "CPV"
    },
    "description": "Cellular Pathology Referrals.",
    "id": "ocds-h6vhtk-0566fe",
    "items": [
      {
        "deliveryAddresses": [
          {
            "region": "UK"
          }
        ],
        "id": "1",
        "relatedLot": "1"
      }
    ],
    "legalBasis": {
      "id": "32014L0024",
      "scheme": "CELEX"
    },
    "lots": [
      {
        "awardCriteria": {
          "criteria": [
            {
              "description": "100",
              "name": "the existing provider is satisfying the original contract and will likely satisfy the proposed contract to a sufficient standard.",
              "type": "cost"
            }
          ]
        },
        "description": "Description of Services; The contract is for the provision of cellular pathology tests.\nContract Award Statement: The intention is to award the contract to University Hospitals Birmingham NHS Foundation Trust following the direct award process C under the Provider Selection Regime.\nContract Value: The approximate lifetime value of the contract is \u00a335000.\nContract Period: The services are intended to be provided from 2025 to 2026.",
        "hasOptions": false,
        "id": "1",
        "status": "cancelled"
      }
    ],
    "mainProcurementCategory": "services",
    "procurementMethod": "limited",
    "procurementMethodDetails": "Award procedure without prior publication of a call for competition",
    "procurementMethodRationale": "This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2023 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to the relevant authority by 6th August 2025. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.",
    "procurementMethodRationaleClassifications": [
      {
        "description": "The procurement falls outside the scope of application of the directive",
        "id": "D_OUTSIDE_SCOPE",
        "scheme": "TED_PT_AWARD_CONTRACT_WITHOUT_CALL"
      }
    ],
    "status": "complete",
    "title": "Cellular Pathology Referrals - University Hospitals Birmingham"
  }
}